At a glance
- What the study gets you
- Health checks and monitoring — no treatment given
- Type of study
- Observational (no treatment given)
- Time in hospital
- In-person visits at study sites — visit count not specified by the sponsor
- Drug or intervention
- No Intervention: Observational Cohort (other)
- How long the study runs
- Study runs about 4 months (dates as stated)
- About the drug or intervention
- No Intervention: Observational Cohort — other: No Intervention, Observational Cohort
- Patient visit burden
- Not specified by the sponsor
- Type of study
- Observing health over time
- Ages
- 18 Years and over
- Who
- All
- Number of participants
- 2
- Started
- 2026-03-31
- Last checked
- 2026-08
Plain English Summary
What is this study?
- • Testing a new treatment for obesity and obesity-related medical conditions
- • Clinical study - 2 participants
- • The objective of this study is to assess the long term weight loss and weight loss journey of patients who received an Endoscopic Sleeve Gastroplasty (ESG) 5 or more years prior to enrollment
Who can take part?
- • Ages 18 Years and over
- • Diagnosed with obesity and obesity-related medical conditions
Where?
- • No UK sites listed for this trial
This is a simplified summary. Always discuss with your doctor before making any decisions.
About This Trial
The objective of this study is to assess the long term weight loss and weight loss journey of patients who received an Endoscopic Sleeve Gastroplasty (ESG) 5 or more years prior to enrollment.
More detail
Includes retrospective data collection and one prospective visit
Obesity and Obesity-related Medical ConditionsWeight Loss
How this trial compares with your answers
Answer 2 more questions to improve match
What we know so far
Condition· Matched your search
Age· Tell us your age for better matching
Gender· Tell us your sex for better matching
Still need:
- • Tell us your age for better matching
- • Tell us your sex for better matching
Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.
Eligibility at a Glance
Key info
- Age: 18 Years and over
- Who can join: All genders
What the study is looking for
- ✓Subject is ≥ 18 years of age at the time of the ESG procedure
- ✓Subject with a BMI between 30 kg/m2 and 50 kg/m2, inclusive, at the time of the primary ESG procedure using...
- ✓Subject completed follow-up 1-year from the ESG procedure for weight loss management
- ✓Subject completed or is eligible for follow-up 5-years from the ESG procedure for weight loss management (visit can...
- ✓Subject has returned for a minimum of one annual follow-up at the treating site for weight loss management annually...
See the full criteria
Inclusion Criteria:
* Subject is ≥ 18 years of age at the time of the ESG procedure
* Subject with a BMI between 30 kg/m2 and 50 kg/m2, inclusive, at the time of the primary ESG procedure using Overstitch Endoscopic Suturing System
* Subject completed follow-up 1-year from the ESG procedure for weight loss management
* Subject completed or is eligible for follow-up 5-years from the ESG procedure for weight loss management (visit can be collected either retrospectively or prospectively)
* Subject has returned for a minimum of one annual follow-up at the treating site for weight loss management annually between two and four years from the procedure.
* Subject is willing to complete one prospective visit (5 year or 5+ year, as appropriate)
* Subject is able to read, understand, and sign a written Informed Consent Form to participate in the study
Exclusion Criteria:
* None
Data sourced from ClinicalTrials.gov · Last verified: 2026-08